Nitazoxanide

Routes
Oral (PO)
Half-Life (t½)
PO: 1.5h
Formula
C12H9N3O5S
Molecular Weight
307.28 g/mol
PubChem CID
41684
Aliases
Alinia

Pharmacological Mechanism

Broad-spectrum antiparasitic + antiviral — interferes with pyruvate:ferredoxin oxidoreductase (PFOR) electron transfer in anaerobic protozoa. Approved for cryptosporidiosis + giardiasis; off-label for rotavirus and other viruses with mixed evidence.

Half-Life & Elimination Curve (PO: 1.5h)

100%50%25%12.5%0%0h0×t½1.5h1×t½3h2×t½4.5h3×t½6h4×t½7.5h5×t½0×t½ (0h): 100% remaining (~1.48 mg/L)1×t½ (1.5h): 50% remaining (~0.742 mg/L)2×t½ (3h): 25% remaining (~0.371 mg/L)3×t½ (4.5h): 12.5% remaining (~0.186 mg/L)4×t½ (6h): 6.3% remaining (~92.8 µg/L)5×t½ (7.5h): 3.1% remaining (~46.4 µg/L)
Plasma (PO)t½ Decay (1.5h)
  • 0×t½0h100% (1.48 mg/L)
  • 1×t½1.5h50% (0.742 mg/L)
  • 2×t½3h25% (0.371 mg/L)
  • 3×t½4.5h12.5% (0.186 mg/L)
  • 4×t½6h6.3% (92.8 µg/L)
  • 5×t½7.5h3.1% (46.4 µg/L)
Elimination t½1.5h (PO)
Rate Constant (ke)0.462 h⁻¹
Time to Peak (Tmax)1.52h
Est. Peak (Cmax)1.48 mg/L
Clearance (CL)23.1 L/h
97% Washout (5×t½)7.5h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References